ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 248,36
0,74%
Dow Jones
39 387,76
0,85%
DAX
18 827,34
0,79%
Brent Oil
83,89
-0,07%
Bitcoin
62 943,68
-0,17%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Citigroup Fdg (CTH)

  7. Citigroup Fdg (CTH) Actualités

CTH

Citigroup Fdg (CTH)

Citigroup Fdg
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:CTH
DateHeureSourceTitreSymboleSociété
15/08/201612h00GlobeNewswireCynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allow...AMEX:CTHCitigroup Fdg
18/07/201622h10GlobeNewswireCynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episod...AMEX:CTHCitigroup Fdg
30/06/201614h00GlobeNewswireCynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients ...AMEX:CTHCitigroup Fdg
30/05/201608h00GlobeNewswireCynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual MeetingAMEX:CTHCitigroup Fdg
15/04/201612h00GlobeNewswireCynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual MeetingAMEX:CTHCitigroup Fdg
08/12/201508h00GlobeNewswireCynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson's Disease and Related Disorders Me...AMEX:CTHCitigroup Fdg
17/07/201422h15GlobeNewswireCynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesAMEX:CTHCitigroup Fdg
08/07/201407h00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Re...AMEX:CTHCitigroup Fdg
14/05/201412h00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Park...AMEX:CTHCitigroup Fdg
24/04/201412h00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's Dise...AMEX:CTHCitigroup Fdg
28/03/201411h00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-...AMEX:CTHCitigroup Fdg
13/01/201412h00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277AMEX:CTHCitigroup Fdg
15/05/201307h00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Dise...AMEX:CTHCitigroup Fdg
24/03/200617h00PR Newswire (US)American Stock Exchange Lists Citigroup Funding Inc.'s 7.5% Sequins Linked to UnitedHealth Group Inc.AMEX:CTH
 Showing the most relevant articles for your search:AMEX:CTH

Dernières Valeurs Consultées

EU
GLE
Societe Generale
EU
PX1
CAC 40
FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
EU
BN
Danone
EU
ACA
Credit Agricole
EU
PX4
SBF 120
NYSE
MCD
McDonalds
EU
EN
Bouygues
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés